ArticleBreast cancer research and treatment2025

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: The impact of the KATHERINE trial.

Lauren N Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.